Ask Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.25 Cr
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 4.00 Cr
- Revenue Growth -29.05%
- Profit Growth 27.91%
- Ebitda 27.91%
- Net Worth 29146.43%
- Total Assets 3294.03%
About Ask Pharma India
Ask Pharma India Private Limited (APIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 2016 (Eight years and three months 27 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹4.00 Cr.
Hanumantha Kotha, Vamsi Penugonda, and Ramakrishna Tota serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24290TG2016PTC112495
-
Company No.
112495
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Oct 2016
-
Date of AGM
24 Jan 2020
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ask Pharma India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanumantha Kotha
|
Director | 09-Jan-2018 | Current |
|
Vamsi Penugonda
|
Director | 20-Nov-2018 | Current |
|
Ramakrishna Tota
|
Director | 29-Jun-2020 | Current |
Financial Performance of Ask Pharma India.
Ask Pharma India Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 29.05% decrease. The company also saw a substantial improvement in profitability, with a 27.91% increase in profit. The company's net worth Soared by an impressive increase of 29146.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ask Pharma India?
In 2018, Ask Pharma India had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2021 | Uco Bank | ₹4.00 Cr | Open |
How Many Employees Work at Ask Pharma India?
Unlock and access historical data on people associated with Ask Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ask Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ask Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
